Z-JANS was founded in 1998 with a clear ambition: to build a pharmaceutical company driven by quality, innovation and a strong understanding of evolving healthcare needs.
Our journey beyond Pakistan began in 2001, when we entered the export market and started building the foundation for a broader international presence.
In 2002, we expanded further into specialised pharmaceuticals with the introduction of Ziclopil 4, developed for the management of migraine. This reflected our early focus on identifying specific healthcare needs and developing products within specialised therapeutic categories.
A year later, in 2003, we entered the sweetener category, becoming one of the early pharmaceutical companies in Pakistan to introduce a dedicated sweetener range. This marked an important step in our evolution beyond conventional pharmaceuticals and into emerging areas of consumer healthcare.
As our pharmaceutical capabilities expanded, Z-JANS progressed into more specialised therapeutic areas. This included the manufacture of URO-Z, a hydroxyurea-based anti-cancer medicine, marking an important step in the development of our specialized pharmaceutical portfolio.
In 2015, we expanded into nutraceuticals, broadening our focus into nutrition, supplementation and everyday well being while continuing to strengthen our pharmaceutical portfolio.